Product Information
LISDEXAMFETAMINE 30 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $3.0366 per EA under NDC 70010020801. Its NADAC has been published 63 times since Apr 16, 2025.
Strength
30 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010020801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA218987On Market Since
1/29/2025
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has been published 63 times since Apr 16, 2025, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0366 per EA |
|---|---|
| All-time high | $4.2619 (Apr 16, 2025) |
| All-time low | $2.9584 (Mar 18, 2026) |
| 52-week high | $3.9018 |
| 52-week low | $2.9584 |
| Median price | $3.4369 |
| Average price | $3.4778 |
| Largest weekly change | -6.4% (Feb 18, 2026) |
| Weeks tracked | 63 |
| Tracking since | Apr 16, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $3.0366 per EA (NDC 70010020801), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has declined 28.8%. It has been tracked across 63 weekly CMS publications since Apr 16, 2025.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG CAPSULE?
Since Apr 16, 2025, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has ranged from a low of $2.9584 (Mar 18, 2026) to a high of $4.2619 (Apr 16, 2025), with a median of $3.4369 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LISDEXAMFETAMINE 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 30 MG CAPSULE?
LISDEXAMFETAMINE 30 MG CAPSULE (NDC 70010020801) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification